One Stop Shop for All Your Market Research Reports

NK Cell Therapy Market - Global Outlook and Forecast 2022-2028

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells. This report contains market size and forecasts of NK Cell Therapy in Global, including the following market information: Global NK Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions) Global top five companies in 2021 (%) The global NK Cell Therapy market was valued at 357.9 million in 2021 and is projected to reach US$ 981.5 million by 2028, at a CAGR of 15.5% during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. NK Cell Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of NK Cell Therapy include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma and NantWorks, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the NK Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global NK Cell Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions) Global NK Cell Therapy Market Segment Percentages, by Type, 2021 (%) NK Cell Therapies NK Cell Directed Antibodies Global NK Cell Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions) Global NK Cell Therapy Market Segment Percentages, by Application, 2021 (%) Cancer Gastrointestinal Diseases Others Global NK Cell Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) Global NK Cell Therapy Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies NK Cell Therapy revenues in global market, 2017-2022 (estimated), ($ millions) Key companies NK Cell Therapy revenues share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Nektar Therapeutics Innate Pharma SA Affimed Chipscreen Biosciences Fate Therapeutics Glycostem Therapeutics Dragonfly Therapeutics Kiadis Pharma NantWorks Nkarta Therapeutics Fortress Biotech
1 Introduction to Research & Analysis Reports 1.1 NK Cell Therapy Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global NK Cell Therapy Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Yea
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3250
Multi User US $4225
Corporate User US $4875
About this Report
Report ID 928436
  • Medical Devices
Published on 06-May
Number of Pages 74
Publisher Name Market Monitor Global
Editor Rating